3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
1
Appendiceal Neoplasms
1
Adenocarcinoma, Mucinous
1
Interventions
Mitomycin
9
Oxaliplatin
7
Hyperthermic Intraperitoneal Chemotherapy
7
Leucovorin
5
Irinotecan
5
Fluorouracil
4
Surveys and Questionnaires
3
Cisplatin
3
Capecitabine
3
dehydroftorafur
2
Thalidomide
2
Mitozytrex
2
Doxorubicin
2
Cytoreduction Surgical Procedures
2
Biopsy
2
surufatinib
1
sintilimab
1
nintedanib
1
irinotecan sucrosofate
1
durvalumab
1
Yoga
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Psychiatric Rehabilitation
1
Platinum
1
Pharmacogenomic Testing
1
Palonosetron
1
Pafolacianine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Appendiceal Neoplasms
×
DNA Fingerprinting
×
Clear all
NCT05734430
2025-04-18
GAP
Vanderbilt-Ingram Cancer Center
Recruiting
700 enrolled